Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: personal experience over 5 years.

Abstract

BACKGROUND:

Polymethylmethacrylate microspheres/collagen has been used in Canada since 1998. A closely related product will probably be approved in the United States shortly. Concerns have been expressed about the use of permanent fillers such as this.

OBJECTIVE:

This retrospective study of the authors' clinical practice is designed to reflect their experience with this agent. In particular, the authors describe some of the problems they have seen.

RESULTS:

Polymethylmethacrylate microspheres/collagen has behaved as a satisfactory long-term tissue augmenting agent in the authors' practice. They have had the opportunity of managing any number of patients with Artecoll granulomas and describe these patients.

CONCLUSION:

When polymethylmethacrylate microspheres/collagen is introduced to the United States, practitioners will need to learn how to use this exacting agent and will obtain excellent results with careful use.

• Authors: Alastair Carruthers, Jean D A Carruthers
• Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 31 Issue 11 Pt 2 Pg. 1561-4; discussion 1565 (Nov 2005) ISSN: 1076-0512 [Print] United States
• PMID: 16416639 (Publication Type: Journal Article)

Chemical References

• Artecoll
• Biocompatible Materials
• Collagen
• Polymethyl Methacrylate

Topics

• Biocompatible Materials
• Canada
• Collagen (administration & dosage, adverse effects)
• Cosmetic Techniques
• Face
• Granuloma (chemically induced)
• Humans
• Microspheres
• Polymethyl Methacrylate (administration & dosage, adverse effects)
• Retrospective Studies